Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT05811247
Other study ID # APC-APN-304
Secondary ID
Status Active, not recruiting
Phase Phase 3
First received
Last updated
Start date August 28, 2023
Est. completion date June 2025

Study information

Verified date September 2023
Source Apnimed
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is a Phase 3 Randomized Double-Blind Placebo-Controlled 1-year Parallel-Arm Study to Compare a Fixed Dose Combination of AD109 to Placebo in Obstructive Sleep Apnea.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 660
Est. completion date June 2025
Est. primary completion date June 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: 1. =18 years of age at the time of informed consent. 2. PSG criteria: AHI of >5; = 25% central or mixed apneas; and PLM arousal index =15 3. PROMIS-Fatigue: raw score =17 4. PAP intolerance or current PAP refusal. 5. BMI between 18.5 and 40 kg/m2 for men, or 42 kg/m2 for women, inclusive. Exclusion Criteria: 1. Narcolepsy, restless leg syndrome, REM sleep behavior disorder 2. Insomnia disorder characterized by difficulty initiating or maintaining sleep, or use within the past month of sedative-hypnotics or other medication for the purpose of treating or avoiding insomnia symptoms. 3. Pierre Robin, Treacher Collins, or other craniofacial malformation syndrome, or grade =3 tonsillar hypertrophy. 4. Clinically significant cardiac disease, e.g., ventricular arrhythmia, untreated or unstable coronary artery disease, cardiac failure. Stable atrial arrhythmia is allowed. 5. Neuromuscular disorder (e.g., motor neuron disease, muscular dystrophy or myopathy, myasthenic syndrome); epilepsy; Parkinson, Alzheimer, or other neurodegenerative disease.

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
AD109
Oral administration at bedtime.
Placebo
Oral administration at bedtime.

Locations

Country Name City State
United States Maimonides Sleep Arts and Sciences Albuquerque New Mexico
United States Orange County Research Institute Anaheim California
United States NeuroTrials Research Atlanta Georgia
United States FutureSearch Trials of Neurology Austin Texas
United States Sleep Disorders Center of Alabama Birmingham Alabama
United States Alpine Clinical Research Center Boulder Colorado
United States Teradan Clinical trials LLC Brandon Florida
United States NeuroScience Research Center, LLC Canton Ohio
United States Chandler Clinical Trials Chandler Arizona
United States Lowcountry Lung and Critical Care Charleston South Carolina
United States St Lukes Hospital Chesterfield Missouri
United States Chicago Research Center Inc Chicago Illinois
United States CTI Clinical Research Center Cincinnati Ohio
United States Sleep Management Institute Cincinnati Ohio
United States St. Francis Medical Institute Clearwater Florida
United States Nouvelle Clinical Research Cutler Bay Florida
United States Arrow Clinical Trials Daytona Beach Florida
United States CenExel iResearch Decatur Georgia
United States Mountain View Clinical Research, Inc. Denver Colorado
United States Research Carolina Elite Denver North Carolina
United States Ohio Sleep Medicine Institute Dublin Ohio
United States Clinilabs, Inc Eatontown New Jersey
United States Clinical Research of Gastonia Gastonia North Carolina
United States Sleep Disorders Centers of the Mid-Atlantic Glen Burnie Maryland
United States Velocity Clinical Research - Greenville Greenville South Carolina
United States Healthcare Research Network Hazelwood Missouri
United States Henderson Clinical Trials Henderson Nevada
United States Cenexel Research Centers of America - Hollywood Hollywood Florida
United States Advanced Respiratory and Sleep Medicine, LLC Huntersville North Carolina
United States Marvel Clinical Research, LLC Huntington Beach California
United States Western Michigan University Homer Stryker M.D. School of Medicine Kalamazoo Michigan
United States Preferred Research Partners, Inc. Little Rock Arkansas
United States CenExel CNS Los Alamitos California
United States Santa Monica Clinical Trials Los Angeles California
United States Sleep Practitioners, LLC Macon Georgia
United States Brian Abaluck, LLC Malvern Pennsylvania
United States Clinical Neuroscience Solutions - Memphis Memphis Tennessee
United States Ivetmar Medical Group LLC Miami Florida
United States PharmaDev Clinical Research Institute, LLC Miami Florida
United States Coastal Carolina Health Care New Bern North Carolina
United States Northwell Health Physician Partners New Hyde Park New York
United States Neurocare, Inc Newton Massachusetts
United States Infinity Medical Research North Dartmouth Massachusetts
United States Great Plains Health North Platte Nebraska
United States Nuvance Health Norwalk Connecticut
United States Henry Ford Health (Sleep Research Department) Novi Michigan
United States Renstar Medical Research Ocala Florida
United States UPMC Comprehensive Lung Center - Sleep Medicine Pittsburgh Pennsylvania
United States Empire Clinical Research Pomona California
United States Northwest Research Center Portland Oregon
United States Meridian Clinical Research Raleigh North Carolina
United States Centricity Research Rincon Pulmonology Rincon Georgia
United States Velocity Clinical Research Rockville Maryland
United States Central Texas Neurology Consultants, PA Round Rock Texas
United States Clayton Sleep Institute Saint Louis Missouri
United States Sleep Therapy Research Center San Antonio Texas
United States Pacific Research Network San Diego California
United States SDS Clinical Trials Inc. Santa Ana California
United States Baystate Medical Center (BMC) - Baystate Sleep Medicine Springfield Massachusetts
United States Clinical Neurophysiology Services Sterling Heights Michigan
United States Medster Research Valdosta Georgia
United States Sleep Disorders Centers of the Mid-Atlantic Vienna Virginia
United States Palm Beach Research ClinEdge-PPDS West Palm Beach Florida
United States Clinical Site Partners, LLC dba Flourish Research Winter Park Florida

Sponsors (1)

Lead Sponsor Collaborator
Apnimed

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Efficacy of AD109 on airway obstruction in mild to severe OSA Proportion of participants with reduction in AHI (AHI, average number of events for every hour of sleep), measured by polysomnography 6 months
See also
  Status Clinical Trial Phase
Completed NCT05404438 - Mouth Breathing Habits Improvement Intervention N/A
Recruiting NCT05960175 - Impact of Patient Involvement in Alerts Management of Telemonitoring CPAP N/A
Recruiting NCT05813275 - Parallel-Arm Study to Compare AD109 to Placebo With Patients With OSA (SynAIRgy Study) Phase 3
Completed NCT05075668 - Efficacy of HFNC as an Alternative to CPAP Therapy in Surgical Patients With Suspected Moderate to Severe OSA N/A
Completed NCT05881512 - Early Feasibility Study of Transcutaneous Upper Airway Stimulation in Obstructive Sleep Apnea N/A
Completed NCT03336515 - Validity of a Vibrating Postural Device for the Treatment of Positional Obstructive Sleep Apnea (Postural) N/A
Not yet recruiting NCT05944965 - Pharyngeal Muscle Control Mechanisms of Atomoxetine-plus-oxybutynin in Obstructive Sleep Apnea Phase 1/Phase 2
Completed NCT02387476 - Non-Inferiority Study of the FRESCA Mask Versus Existing CPAP Mask for Treatment of Obstructive Sleep Apnea N/A
Not yet recruiting NCT06058052 - Prevalence of OSA in Patients of ILD
Recruiting NCT03721445 - Could HRV be a Valuable Predictor for CPAP Adherence?
Completed NCT03172130 - Sham CPAP vs. Straight CPAP for Chronic Cough N/A
Recruiting NCT06320795 - Prospective Study for the Clinical Validation of the Soundi Wearable Medical Device N/A
Completed NCT01717339 - Sleep Apnea and Vascular Function N/A
Completed NCT00772044 - Randomized Study of Provent Versus Sham Device to Treat Obstructive Sleep Apnea Phase 4
Completed NCT02438137 - Dimethyl Fumarate for Obstructive Sleep Apnea N/A
Completed NCT01672606 - Effect of Rocuronium on the Acute Hypoxic Ventilatory Response in Patients With Obstructive Sleep Apnea N/A
Not yet recruiting NCT06110962 - Detecting Heart Rate, Respiration, and Sleep With the Sleeptracker-AI Under-mattress Monitor
Not yet recruiting NCT06400615 - Study That Tests AD109 in Patients Taking GLP-1 Drugs Phase 2
Completed NCT05060133 - Changes of the Upper Airway Volume After Orthognathic Surgery
Completed NCT03196583 - Efficacy of a Novel MAD in OSA N/A